Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancerFRONTIERS IN IMMUNOLOGYIF5.92025-01-100OAAI
The prognostic values and immune characteristics of polo-like kinases (PLKs) family: A pan-cancer multi-omics analysisHELIYONIF3.62024-04-011OAAI
Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancerFRONTIERS IN IMMUNOLOGYIF5.92023-10-274OAAI
Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics dataFUNCTIONAL & INTEGRATIVE GENOMICSIF3.12023-06-263PRE
CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapyFRONTIERS IN ONCOLOGYIF3.32023-06-143OAAI
Withdrawal notice to: Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data (vol 9, artn e17229 ,2023)HELIYONIF3.62023-06-010OAAI
circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune ResponseCELL TRANSPLANTATIONIF3.22023-04-0710OAAI
Construction and validation of a bladder cancer risk model based on autophagy-related genesFUNCTIONAL & INTEGRATIVE GENOMICSIF3.12023-01-231OA
CircSTK39 suppresses the proliferation and invasion of bladder cancer by regulating the miR-135a-5p/NR3C2-mediated epithelial-mesenchymal transition signaling pathwayCELL BIOLOGY AND TOXICOLOGYIF5.92022-12-208PRE
Pan-cancer analysis of the prognostic and immunological role of PAQR4SCIENTIFIC REPORTSIF3.92022-12-083OAAI
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancerFRONTIERS IN ONCOLOGYIF3.32022-10-109OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向